Free Hematology CME | CMEList.com

 


Advancing Treatment Strategies in Multiple Myeloma (MM) Drug Therapy Free oncology CME Free Hematology CME
Posted by...Bernard Sklar, MD.
Free Oncology and Hematology CME Credit Hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Target Audience...Hematologists and oncologists; physician assistants, nurse practitioners, nurses, and pharmacists who practice in oncology; and any other healthcare professionals with an interest in or who clinically encounter patients with MM.
Educational material updated...November 02, 2017.
Expiration of CME credit...November 02, 2019.
Financial Support...Amgen
The goal of Advancing Treatment Strategies in Multiple Myeloma (MM) Drug Therapy is to help you to discern the role of each of the first-line and more novel therapies, including monoclonal antibodies and proteasome, deacetylase, and 3 serine/threonine protein kinase inhibitor therapies in the treatment of multiple myeloma.
By the end of Advancing Treatment Strategies in Multiple Myeloma (MM) Drug Therapy , you will be able to:
• Recall updates in the staging, prognosis, and diagnosis of MM.
• Distinguish between the most appropriate treatment approaches to MM and apply them to practice, taking into account the following: treatment modalities and the recent clinical trial evidence supporting them.
• Distinguish between the most appropriate treatment approaches to MM and apply them to practice, taking into account the following: evidence-based treatment guidelines, algorithms, and expert opinion.
• Summarize the risk-benefit profiles of current and emerging therapies for the treatment of MM.

Risky Business: Diagnosing and Treating Invasive Fungal Infections
Free Fungal Infection CME Posted by...Bernard Sklar, MD.
Free CME Credit Hours...1.0.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Slide-Video Lectures.
Target Audience...Hematologist-oncologists, medical oncologists, transplant surgeons, critical care surgeons, critical care pulmonologists, and other health care professionals involved in the treatment of patients with or at risk for invasive fungal infections.
Educational material last updated...April 18, 2017.
CME Credit Expires...April 17, 2018.
Financial Support...Astellas.
Risky Business: Diagnosing and Treating Invasive Fungal Infections consists of 3 brief lectures on the diagnosis and treatment of invasive fungal infection:
After completing Risky Business: Diagnosing and Treating Invasive Fungal Infections, you should be better able to:
• Describe the epidemiology and burden of invasive fungal infections in patients who are immunocompromised and/or Immunosuppressed.
• Incorporate the latest diagnostic techniques for invasive fungal infections to ensure that the appropriate therapy can be initiated in a timely manner.
• Integrate the latest evidence-based treatment guidelines and clinical data pertaining to the efficacy, safety, and prophylactic use of antifungal agents to optimize the management of invasive fungal infections.

ScientiaCME Hematology/ Oncology  ScientiaCME Oncology  
Posted by...Bernard Sklar, MD.
Free Oncology CME Credit Hours...7.25.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Target Audience...HEMATOLOGY.
CME Credit Expires...Two years after release.
Financial Support...Various commercial supporters.

ScientiaCME Treatment strategies in Gaucher disease Free Gaucher Disease CME
CME Credit Hours...1.25.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Target Audience...Cardiology, genetic disorders, hematology, oncology, orthopedics, gastroenterology, neurology and pediatrics.
Educational material updated....February 12, 2017.
Expiration of CME credit...February 12, 2019.
Financial Support...Shire.
At the conclusion of By the end of Treatment strategies in Gaucher disease, you will be able to:
• Describe the importance of appropriate GD (Gaucher Disease) diagnosis and treatment (use • for bullets)
• Determine the likelihood of GD using with established diagnosis methods, given a patient case
• Describe present therapies for the treatment of GD and the literature supporting their use
• Design a medical plan to treat a patient with GD, taking into account presently available therapies